Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,882 stories indexed, page 164 of 165

🌍Industrycamp.com

Holiday Ornament Making with Kid Made Modern

CAMP4 TherapeuticsOriginal source
🌍Industrycamp.com

2019 My Best Self! Craft Class

CAMP4 TherapeuticsOriginal source
🌍Industrycamp.com

Roller Pin Rainbows for Pride!

CAMP4 TherapeuticsOriginal source
🌍Industrycamp.com

Make Your Own Merit Badge

CAMP4 TherapeuticsOriginal source
🌍Industrycamp.com

Embroider Your Own Merit Badge

CAMP4 TherapeuticsOriginal source
🌍Industrycamp.com

Make Your Own CAMP Pennant

CAMP4 TherapeuticsOriginal source
🌍Industrycamp.com

Mixed Media Holiday Card Workshop

CAMP4 TherapeuticsOriginal source
🌍Industrycamp.com

Here's to 2019 Holiday Card Workshop

CAMP4 TherapeuticsOriginal source
🌍Industrycamp.com

CAMP | Immersive Kids Activities, Slime, Crafts & Birthday Parties

CAMP4 TherapeuticsOriginal source
🇨🇭Industrybioscience.lonza.com

What Are Stem Cells? | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Introduction to Hippocampal Neurons | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Primary Neurons and Glial Cells | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Primary Immune Cells and Media | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

| Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

MycoAlert® Mycoplasma Detection | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Mycoplasma contamination of cell cultures | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

MSCs - Mesenchymal Stem Cells

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Cortical Neurons | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Introduction to Astroglia | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Hematopoietic Stem Cell Therapy | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Endothelial Primary Cells | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

CellBio Services | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Cell Culture Techniques | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Cell Assays and Analysis | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Cell and Gene Therapy | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

CD34+ Positive Cells | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Culture Media and Reagents | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

An Introduction to Primary Cell Culture | Lonza

Lonza BioscienceOriginal source
🇨🇭Industrybioscience.lonza.com

Airway Cells and Media | Lonza

Lonza BioscienceOriginal source
🌍Industrybioaffinitytech.com

Israel Elias Garcia, MSN discuses the benefits of CyPath® Lung – bioAffinity

bioAffinity TechnologiesOriginal source
🌍Industrybioaffinitytech.com

“Not every single nodule needs a biopsy…” Sai Karan “Vamsi” Guda, DO – bioAffinity

bioAffinity TechnologiesOriginal source
🌍Industrybioaffinitytech.com

“Lung cancer can happen anywhere, and the trick is finding it sooner than later.” Gregory White, MD – bioAffinity

bioAffinity TechnologiesOriginal source
🌍Industrybioaffinitytech.com

“I needed a real-time test…that could tell me there is a tumor cell.” Gordon Downie, MD, PhD

bioAffinity TechnologiesOriginal source
🌍Industrybioaffinitytech.com

“I can sleep at night and not worry that maybe I’m missing a malignancy…” Daya Nadarajah, MD – bioAffinity

bioAffinity TechnologiesOriginal source
🌍Industrybioaffinitytech.com

Negative CyPath® Lung Test Result Prevented Biopsy – bioAffinity

bioAffinity TechnologiesOriginal source
🌍Industrybioaffinitytech.com

Positive CyPath® Lung Test Result Led to Diagnosis of Lung Cancer at Earliest Stage 1A – bioAffinity

bioAffinity TechnologiesOriginal source
🌍Industrybioaffinitytech.com

bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells – bioAffinity

bioAffinity TechnologiesOriginal source
🌍Industrybioaffinitytech.com

bioAffinity Technologies Announces Pricing of $3.2 Million Offering – bioAffinity

bioAffinity TechnologiesOriginal source
🌍Industrybioaffinitytech.com

bioAffinity Technologies Announces Closing of $3.2 Million Offering – bioAffinity

bioAffinity TechnologiesOriginal source
🇺🇸Industrybilliontoone.com

BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - BillionToOne

BillionToOneOriginal source
🇺🇸Industrybilliontoone.com

BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026 - BillionToOne

BillionToOneOriginal source
🇺🇸Industrybilliontoone.com

BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference - BillionToOne

BillionToOneOriginal source
🇺🇸Industrybilliontoone.com

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance - BillionToOne

BillionToOneOriginal source
🇺🇸Industrybilliontoone.com

BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance - BillionToOne

BillionToOneOriginal source
🇺🇸Industrybilliontoone.com

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics - BillionToOne

BillionToOneOriginal source
🇺🇸Industrybilliontoone.com

BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select® - BillionToOne

BillionToOneOriginal source
🇺🇸Industrybilliontoone.com

BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology - BillionToOne

BillionToOneOriginal source
🇺🇸Researchascopubs.org

Bridging the Gap: Integrating External Beam Radiation Therapy Into the Management of Hepatocellular Carcinoma

ASCO JCO JournalOriginal source
🇺🇸Researchascopubs.org

A Shopping List

ASCO JCO JournalOriginal source
🇺🇸Researchascopubs.org

No Smoker Left Behind: Evaluation of a Population-Based, Opt-Out Smoking Cessation Program for Patients With Cancer Who Smoke

ASCO JCO JournalOriginal source
🇺🇸Researchascopubs.org

From Darkness to Light

ASCO JCO JournalOriginal source
🇺🇸Industryargenx.com

argenx Stories

argenx USOriginal source
🇫🇷Regulatoryansm.sante.fr

Rapports d'enquêtes de vigilance

French National Agency for Medicines and Health Products Safety (ANSM)Original source
🇫🇷Regulatoryansm.sante.fr

Publications scientifiques

French National Agency for Medicines and Health Products Safety (ANSM)Original source
🇫🇷Regulatoryansm.sante.fr

Protection des données à caractère personnel et politique de confidentialité

French National Agency for Medicines and Health Products Safety (ANSM)Original source
🇫🇷Regulatoryansm.sante.fr

Opérations réalisées par l'ANSM donnant lieu au paiement d'un droit

French National Agency for Medicines and Health Products Safety (ANSM)Original source
🇫🇷Regulatoryansm.sante.fr

- Consulter nos newsle t ters

French National Agency for Medicines and Health Products Safety (ANSM)Original source
🇫🇷Regulatoryansm.sante.fr

Mentions légales

French National Agency for Medicines and Health Products Safety (ANSM)Original source
🇫🇷Regulatoryansm.sante.fr

Les médicaments et moi

French National Agency for Medicines and Health Products Safety (ANSM)Original source